Viral and host responses after stopping long-term Nucleos(t)ide analogue therapy in HBeAg-negative chronic Hepatitis B

Journal of Infectious Diseases

Volumn 214, Issue 10, 2016, Pages 1492-1497

  Höner Zu Siederdissen, Christoph ^a   Rinker, Franziska ^a   Maasoumy, Benjamin ^a   Wiegand, Steffen B ^a   Filmann, Natalie ^a   Falk, Christine S ^b   Deterding, Katja ^a   Port, Kerstin ^a   Mix, Carola ^a   Manns, Michael P ^a,b   Herrmann, Eva ^a   Wedemeyer, Heiner ^a,b   Kraft, Anke R M ^a   Cornberg, Markus ^a  

^a GOETHE UNIVERSITY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

CXCL10; cytokines; HBsAg; hepatitis B virus infection; IP 10; nucleos(t)ide analogues; stopping treatment

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; NUCLEOSIDE ANALOG; TUMOR NECROSIS FACTOR; VIRUS DNA; ANTIVIRUS AGENT; CYTOKINE; HEPATITIS B(E) ANTIGEN; NUCLEOSIDE; NUCLEOTIDE;

ADULT; ARTICLE; CHRONIC HEPATITIS B; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE ASSOCIATION; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; FOLLOW UP; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELAPSE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL; AGED; BLOOD; FEMALE; HEPATITIS B, CHRONIC; MALE; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RECURRENT DISEASE; VERY ELDERLY; VIROLOGY;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; CYTOKINES; DNA, VIRAL; FEMALE; HEPATITIS B CORE ANTIGENS; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; MALE; MIDDLE AGED; NUCLEOSIDES; NUCLEOTIDES; PROSPECTIVE STUDIES; RECURRENCE; WITHHOLDING TREATMENT;

EID: 85006399714     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw412     Document Type: Article

References (15)

1. European Association for the Study of the Liver. EASL clinical practice guidelines: management of chronic hepatitis B virus infection. J Hepatol 2012; 57:167-85.
2. Papatheodoridis G, Vlachogiannakos I, Cholongitas E, et al. Discontinuation of oral antivirals in chronic hepatitis B: a systematic review. Hepatology 2016; 63:1481-92.
3. Cornberg M, Höner Zu Siederdissen C. HBsAg seroclearance with NUCs: rare but important. Gut 2014; 63:1208-9.
4. Chang M-L, Liaw Y-F, Hadziyannis SJ. Systematic review: cessation of long-Term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B. Aliment Pharmacol Ther 2015; 42:243-57.
5. Hadziyannis SJ, Sevastianos V, Rapti I, Vassilopoulos D, Hadziyannis E. Sustained responses and loss of HBsAg in HBeAg-negative patients with chronic hepatitis B who stop long-Term treatment with adefovir. Gastroenterology 2012; 143:629-36.e1.
6. Xia Y, Stadler D, Lucifora J, et al. Interferon-γ and tumor necrosis factor-α produced by T cells reduce the HBV persistence form, cccDNA, without cytolysis. Gastroenterology 2016; 150:194-205.
7. Bertoletti A, Ferrari C. Adaptive immunity in HBV infection. J Hepatol 2016; 64 (suppl 1):S71-83.
8. Jaroszewicz J, Ho H, Markova A, et al. Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues. Antivir Ther 2011; 16:915-24.
9. Sonneveld MJ, Arends P, Boonstra A, Hansen BE, Janssen HLA. Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B. J Hepatol 2013; 58:898-903.
10. Schurich A, Pallett LJ, Lubowiecki M, et al. The third signal cytokine IL-12 rescues the anti-viral function of exhausted HBV-specific CD8 T cells. PLoS Pathog 2013; 9:e1003208.
11. Rehermann B. Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells. Nat Med 2013; 19:859-68.
12. Schuch A, Hoh A, Thimme R. The role of natural killer cells and CD8+ T cells in hepatitis B virus infection. Front Immunol 2014; 5:258.
13. Luangsay S, Gruffaz M, Isorce N, et al. Early inhibition of hepatocyte innate responses by hepatitis B virus. J Hepatol 2015; 63:1314-22.
14. Das A, Ellis G, Pallant C, et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol 2012; 189:3925-35.
15. Blackburn SD, Wherry EJ. IL-10, T cell exhaustion and viral persistence. Trends Microbiol 2007; 15:143-6.